Management of Membranous Nephropathy in Western Countries | Zendy

Talal Alfaadhel | Zendy; Daniel Cattran | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Management of Membranous Nephropathy in Western Countries

Author(s) -

Talal Alfaadhel,

Daniel Cattran

Publication year - 2015

Publication title -

kidney diseases

Language(s) - English

Resource type - Journals

eISSN - 2296-9381

pISSN - 2296-9357

DOI - 10.1159/000437287

Subject(s) - medicine , rituximab , calcineurin , nephrotic syndrome , membranous nephropathy , population , cyclophosphamide , malignancy , immunosuppression , kidney disease , glomerulonephritis , prednisone , intensive care medicine , immunology , kidney , transplantation , lymphoma , chemotherapy , environmental health

Idiopathic membranous nephropathy (IMN) is a common cause of nephrotic syndrome (NS) in adults in Western countries. In 2012, the KDIGO (Kidney Disease: Improving Global Outcomes) working group published guidelines for the management of glomerulonephritis, thus providing a template for the treatment of this condition. While being aware of the impact of the clinicians' acumen and that patients may choose a different therapeutic option due to the risks of specific drugs and also of the evolving guidelines, this review details our approach to the management of patients with IMN in a Western center (Toronto).

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research